Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Spadafora

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Journal of Cardiovascular Pharmacology|November 21, 2022
Step-wise Lipid-Lowering Therapy: Thinking Beyond the GuidelinesAnnachiara Pingitore, Luigi Spadafora, Giuseppe Biondi-Zoccai, et al.
International Journal of Cardiology|January 13, 2022
The cardiologist's commandment: Thou shalt not retract!Luigi Spadafora, Alberto Testa, Giacomo Frati, et al.
Journal of Cardiovascular Pharmacology|October 10, 2022
Magnitude of Low-density Lipoprotein Reduction and Impact on Major Cardiovascular OutcomesSalvatore Giordano, Luigi Spadafora, Giuseppe Biondi-Zoccai, et al.
Interactive Cardiovascular and Thoracic Surgery|July 25, 2022
Coronary artery bypass grafting added to surgical aortic valve replacement in octogenariansLuigi Spadafora, Marco Bernardi, Giuseppe Biondi-Zoccai, et al.
Journal of Cardiovascular Pharmacology|November 11, 2025
A New Era for Cardio-Oncology: Highlights From the Inaugural ESC Cardio-Oncology CongressLuigi Spadafora, Massimiliano Camilli, Svetlana Mosteoru, et al.
International Journal of Cardiology|May 26, 2022
Juvenile myocardial infarction: Sex mattersMarco Bernardi, Luigi Spadafora, Giuseppe Biondi-Zoccai, et al.
Journal of Cardiovascular Pharmacology|March 17, 2023
Statin Therapy After Myocardial Infarction in Patients With Renal Failure: The Longer, the Merrier!Luigi Spadafora, Gabriele Crimi, Italo Porto, et al.
Journal of Cardiovascular Pharmacology|July 7, 2026
Prophylactic ACE inhibition in anthracycline-induced cardiotoxicity: signal, context, and clinical uncertaintyBeatrice Simeone, Erica Rocco, Luigi Spadafora, et al.
Journal of Cardiovascular Pharmacology|September 11, 2024
Rethinking Beta-Blockers After ST-Segment Elevation Myocardial Infarction: Essential for Some, Questionable for OthersFederico Russo, Angela Palma, Stefano Cacciatore, et al.
Archives of Medical Science : AMS|December 2, 2022
Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategiesLuigi Spadafora, Marco Bernardi, Mattia Galli, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Pharmacology|November 21, 2022
Step-wise Lipid-Lowering Therapy: Thinking Beyond the GuidelinesAnnachiara Pingitore, Luigi Spadafora, Giuseppe Biondi-Zoccai, et al.
International Journal of Cardiology|January 13, 2022
The cardiologist's commandment: Thou shalt not retract!Luigi Spadafora, Alberto Testa, Giacomo Frati, et al.
Journal of Cardiovascular Pharmacology|October 10, 2022
Magnitude of Low-density Lipoprotein Reduction and Impact on Major Cardiovascular OutcomesSalvatore Giordano, Luigi Spadafora, Giuseppe Biondi-Zoccai, et al.
Interactive Cardiovascular and Thoracic Surgery|July 25, 2022
Coronary artery bypass grafting added to surgical aortic valve replacement in octogenariansLuigi Spadafora, Marco Bernardi, Giuseppe Biondi-Zoccai, et al.
Journal of Cardiovascular Pharmacology|November 11, 2025
A New Era for Cardio-Oncology: Highlights From the Inaugural ESC Cardio-Oncology CongressLuigi Spadafora, Massimiliano Camilli, Svetlana Mosteoru, et al.
International Journal of Cardiology|May 26, 2022
Juvenile myocardial infarction: Sex mattersMarco Bernardi, Luigi Spadafora, Giuseppe Biondi-Zoccai, et al.
Journal of Cardiovascular Pharmacology|March 17, 2023
Statin Therapy After Myocardial Infarction in Patients With Renal Failure: The Longer, the Merrier!Luigi Spadafora, Gabriele Crimi, Italo Porto, et al.
Journal of Cardiovascular Pharmacology|July 7, 2026
Prophylactic ACE inhibition in anthracycline-induced cardiotoxicity: signal, context, and clinical uncertaintyBeatrice Simeone, Erica Rocco, Luigi Spadafora, et al.
Journal of Cardiovascular Pharmacology|September 11, 2024
Rethinking Beta-Blockers After ST-Segment Elevation Myocardial Infarction: Essential for Some, Questionable for OthersFederico Russo, Angela Palma, Stefano Cacciatore, et al.
Archives of Medical Science : AMS|December 2, 2022
Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategiesLuigi Spadafora, Marco Bernardi, Mattia Galli, et al.
Pageof 9